We first demonstrated that the ALL survivors exhibited increased activation (%HLA-DR) of CD4+ and CD8+ cells, in comparison to controls (Fig. 4a, b), which is consistent with our previous report [35]. The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.